Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
about
Genes, tolerance and systemic autoimmunityImmunodeficiency and autoimmunity: lessons from systemic lupus erythematosusPathogenesis of human systemic lupus erythematosus: recent advances.Advances in lupus stemming from the parent-into-F1 modelDonor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expressionIL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cellsImplications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens.Pre-clinical screening of immunomodulatory compounds using the parent-into-F1 model.Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice.Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a DownT cells, murine chronic graft-versus-host disease and autoimmunity.In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Low-Dose IL-2 in the Treatment of Lupus.Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus.Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease.Impact of head and neck malignancies on risk factors and survival in systemic lupus erythematosus
P2860
Q24615454-5A97C2DF-BA6A-487B-8589-E27F51DE3354Q24632664-0AB9E8CA-88DF-44D1-8723-9BA5E06324AFQ33664927-ADD1C109-76B6-45DD-A508-8023F44EE93EQ33903169-8795E97C-AEBA-43ED-AF8B-E5B850C48BC1Q33967652-680DA4C3-6424-4A16-9130-EB3ECF7FC1F1Q34053939-B2DE00AA-DBE6-49D2-9B29-660433562C03Q35479272-F20E801C-4078-40CF-BF8A-5FAF8D1BDF7FQ35547577-EA599C96-3EC0-4AE4-98EA-1F754BE34233Q35547588-DEFC7E2F-5C60-44A8-93FA-DC0C0C347D2FQ35547605-AC452B9F-D358-40CC-8E55-EE471D60CEAAQ36075382-FC7824CD-F91F-45AE-9019-73F08864FD6CQ36626989-A5BDCE30-6CBA-4E13-B793-299E42064915Q36788495-C4F656A3-E81F-4250-8223-A44942022FC1Q37657613-DFCB9049-F258-43D1-AB66-0C65350A0494Q38182646-BCC4958B-8227-4A0C-B7F5-83501242314FQ38979253-B4EED32D-3F2C-4C3F-B647-85062B519F11Q40376398-9CAC3B0B-2136-4027-AF0E-88EF690A9ABDQ42705255-300DED3B-8923-459D-8FA7-46B23609D7B1Q52316320-288D537F-FBF0-4CAE-AC47-EA4512220B95Q58288029-B65DA830-CA5B-48BA-A987-2410C7B10B86
P2860
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
@ast
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
@en
type
label
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
@ast
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
@en
prefLabel
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
@ast
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
@en
P2093
P2860
P1433
P1476
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE
@en
P2093
P2860
P304
P356
10.1016/J.AUTREV.2008.07.045
P577
2008-08-24T00:00:00Z